Document Detail

Treatment of benign prostatic hypertrophy by a long-acting gonadotropin-releasing hormone analogue: 1-year experience.
MedLine Citation:
PMID:  1703239     Owner:  NLM     Status:  MEDLINE    
Benign prostatic hypertrophy, a common ailment among elderly men, usually is treated by surgery. Since androgens enhance prostatic hypertrophy, their withdrawal seems a logical way to treat this condition. Recently gonadotropin-releasing hormone analogues, known to produce "chemical castration," have been tried in cases of benign prostatic hypertrophy. We report our experience with 20 men treated by a monthly injection of gonadotropin-releasing hormone for prolonged periods. In 17 men treated for 6 months the prostatic volume decreased to an average of 63% of the initial volume; however, this did not correlate with clinical objective improvement. Only 6 men attained normal flow rates. Residual urine volume remained unaltered. Ten patients experienced subjective amelioration, while only 7 (40%) reported objective and subjective improvement. Maximal decrease in prostatic volumes was reached at 9 months of treatment and further treatment did not cause additional shrinkage. At 3 months after discontinuation of treatment prostatic volumes returned to 95 +/- 10.5% of pre-treatment values. A similar decrease in flow rates also was noted. Symptoms remained improved for longer periods. We conclude that this mode of treatment offers little to the majority of men with benign prostatic hypertrophy. Proper patient selection, based perhaps on serum prostate specific antigen, might augment positive results. This therapy should be restricted to patients considered high risk for any surgical and anesthetic intervention, and then it will have to be continued indefinitely.
H Matzkin; J Chen; O Lewysohn; Z Braf
Related Documents :
2515399 - Effects of oestrogen therapy and orchidectomy on coagulation and prostanoid synthesis i...
9072559 - Histopathologic evaluation of the canine prostate following electrovaporization.
18568239 - Is the ability to perform transurethral resection of the prostate influenced by the sur...
9000839 - A comparative study of: long-term alpha-1-blocker, doxazosin therapy versus surgery in ...
6859559 - Na-tartrate in the treatment of chronic nonbacterial prostatitis.
10374789 - Outcome analysis of minimally invasive treatments for benign prostatic hyperplasia.
19220379 - A retrospective review of chronic anal fistulae treated by anal fistulae plug.
11127279 - Impact of the successful flap but failed reconstruction on the true rate of success in ...
15767159 - Cataract surgery in patients with mooren's ulcer.
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  The Journal of urology     Volume:  145     ISSN:  0022-5347     ISO Abbreviation:  J. Urol.     Publication Date:  1991 Feb 
Date Detail:
Created Date:  1991-02-27     Completed Date:  1991-02-27     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0376374     Medline TA:  J Urol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  309-12     Citation Subset:  AIM; IM    
Department of Urology, Timsit Institute for Reproductional Endocrinology, Ichilov Hospital, Tel-Aviv, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Drug Administration Schedule
Gonadotropin-Releasing Hormone / administration & dosage,  analogs & derivatives*,  therapeutic use
Hormones / administration & dosage,  therapeutic use*
Prostatic Hyperplasia / complications,  drug therapy*
Time Factors
Urinary Retention / drug therapy,  etiology*
Reg. No./Substance:
0/Hormones; 33515-09-2/Gonadotropin-Releasing Hormone; 57773-63-4/Triptorelin
Comment In:
J Urol. 1992 Feb;147(2):474   [PMID:  1370700 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Interstitial temperature measurements during transurethral microwave hyperthermia.
Next Document:  Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate canc...